CNMD: Conmed Corp Financial Statements

Balance sheet, income statement, and cash flow statements for Conmed Corp (CNMD).

OverviewDividends

$2.11B Market Cap.

As of 05/01/2025 5:00 PM ET (MRY) • Disclaimer

CNMD Market Cap. (MRY)


CNMD Shares Outstanding (MRY)


CNMD Assets (MRY)


Total Assets

$2.31B

Total Liabilities

$1.34B

Total Investments

$0

CNMD Income (MRY)


Revenue

$1.31B

Net Income

$132.42M

Operating Expense

$532.71M

CNMD Cash Flow (MRY)


CF Operations

$166.97M

CF Investing

-$13.08M

CF Financing

-$151.00M

CNMD Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$2,306,247,000 (0.27%)

$2,300,021,000 (0.11%)

$2,297,592,000 (30.10%)

$1,766,017,000 (0.82%)

Assets Current

$640,007,000 (3.96%)

$615,649,000 (5.92%)

$581,226,000 (26.32%)

$460,123,000 (10.43%)

Assets Non-Current

$1,666,240,000 (-1.08%)

$1,684,372,000 (-1.86%)

$1,716,366,000 (31.43%)

$1,305,894,000 (-2.18%)

Goodwill & Intangible Assets

$1,423,021,000 (-2.29%)

$1,456,328,000 (-2.73%)

$1,497,228,000 (37.54%)

$1,088,577,000 (-2.80%)

Shareholders Equity

$962,681,000 (15.40%)

$834,222,000 (11.89%)

$745,545,000 (-5.08%)

$785,435,000 (10.77%)

Property Plant & Equipment Net

$115,793,000 (-4.08%)

$120,722,000 (4.42%)

$115,611,000 (6.20%)

$108,863,000 (-2.28%)

Cash & Equivalents

$24,459,000 (0.67%)

$24,296,000 (-16.05%)

$28,942,000 (38.83%)

$20,847,000 (-23.79%)

Accumulated Other Comprehensive Income

-$58,857,000 (-17.32%)

-$50,170,000 (13.29%)

-$57,858,000 (-6.74%)

-$54,203,000 (14.88%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$346,719,000 (8.92%)

$318,324,000 (-4.21%)

$332,320,000 (43.46%)

$231,644,000 (18.87%)

Trade & Non-Trade Receivables

$237,733,000 (-1.88%)

$242,279,000 (26.62%)

$191,345,000 (4.06%)

$183,882,000 (3.80%)

Trade & Non-Trade Payables

$102,248,000 (15.90%)

$88,224,000 (20.21%)

$73,393,000 (26.11%)

$58,197,000 (9.17%)

Accumulated Retained Earnings (Deficit)

$560,277,000 (23.81%)

$452,531,000 (9.67%)

$412,631,000 (-16.91%)

$496,605,000 (8.57%)

Tax Assets

$0 (0%)

$11,211,000 (16.18%)

$9,650,000 (-0.07%)

$9,657,000 (41.14%)

Tax Liabilities

$74,076,000 (21.63%)

$60,902,000 (-8.73%)

$66,725,000 (-2.64%)

$68,537,000 (18.42%)

Total Debt

$905,781,000 (-6.99%)

$973,848,000 (-7.68%)

$1,054,822,000 (54.07%)

$684,656,000 (-9.15%)

Debt Current

$715,000 (0.99%)

$708,000 (-98.98%)

$69,746,000 (469.40%)

$12,249,000 (-33.48%)

Debt Non-Current

$905,066,000 (-7.00%)

$973,140,000 (-1.21%)

$985,076,000 (46.50%)

$672,407,000 (-8.54%)

Total Liabilities

$1,343,566,000 (-8.34%)

$1,465,799,000 (-5.56%)

$1,552,047,000 (58.28%)

$980,582,000 (-5.95%)

Liabilities Current

$278,130,000 (-10.49%)

$310,729,000 (4.78%)

$296,552,000 (50.80%)

$196,646,000 (3.39%)

Liabilities Non-Current

$1,065,436,000 (-7.76%)

$1,155,070,000 (-8.00%)

$1,255,495,000 (60.15%)

$783,936,000 (-8.04%)

CNMD Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$1,307,015,000 (5.00%)

$1,244,744,000 (19.06%)

$1,045,472,000 (3.45%)

$1,010,635,000 (17.18%)

Cost of Revenue

$573,983,000 (0.96%)

$568,499,000 (19.88%)

$474,227,000 (7.15%)

$442,599,000 (10.06%)

Selling General & Administrative Expense

$478,280,000 (-4.92%)

$503,040,000 (10.79%)

$454,039,000 (9.47%)

$414,754,000 (10.95%)

Research & Development Expense

$54,426,000 (3.47%)

$52,602,000 (11.56%)

$47,152,000 (8.23%)

$43,565,000 (7.64%)

Operating Expenses

$532,706,000 (-4.13%)

$555,642,000 (-9.39%)

$613,202,000 (33.47%)

$459,446,000 (10.80%)

Interest Expense

$37,297,000 (-6.23%)

$39,775,000 (37.61%)

$28,905,000 (-18.54%)

$35,485,000 (-19.45%)

Income Tax Expense

$30,606,000 (86.98%)

$16,369,000 (68.41%)

$9,720,000 (-7.98%)

$10,563,000 (233.47%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$132,423,000 (105.44%)

$64,459,000 (179.99%)

-$80,582,000 (-228.84%)

$62,542,000 (557.16%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$132,423,000 (105.44%)

$64,459,000 (179.99%)

-$80,582,000 (-228.84%)

$62,542,000 (557.16%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$132,423,000 (105.44%)

$64,459,000 (179.99%)

-$80,582,000 (-228.84%)

$62,542,000 (557.16%)

Weighted Average Shares

$30,890,853 (0.45%)

$30,752,199 (0.89%)

$30,482,412 (4.22%)

$29,247,120 (2.26%)

Weighted Average Shares Diluted

-

-

-

-

Earning Before Interest & Taxes (EBIT)

$200,326,000 (66.10%)

$120,603,000 (387.44%)

-$41,957,000 (-138.64%)

$108,590,000 (137.85%)

Gross Profit

$733,032,000 (8.40%)

$676,245,000 (18.38%)

$571,245,000 (0.56%)

$568,036,000 (23.41%)

Operating Income

$200,326,000 (66.10%)

$120,603,000 (387.44%)

-$41,957,000 (-138.64%)

$108,590,000 (137.85%)

CNMD Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$13,084,000 (34.68%)

-$20,032,000 (91.97%)

-$249,529,000 (-1578.52%)

-$14,866,000 (-9.00%)

Net Cash Flow from Financing

-$151,000,000 (-36.74%)

-$110,432,000 (-149.08%)

$225,000,000 (321.57%)

-$101,548,000 (-95.06%)

Net Cash Flow from Operations

$166,968,000 (33.20%)

$125,348,000 (275.69%)

$33,365,000 (-70.15%)

$111,770,000 (73.20%)

Net Cash Flow / Change in Cash & Cash Equivalents

$163,000 (103.51%)

-$4,646,000 (-157.39%)

$8,095,000 (224.37%)

-$6,509,000 (-533.93%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$227,744,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$13,084,000 (31.25%)

-$19,032,000 (12.64%)

-$21,785,000 (-46.54%)

-$14,866,000 (-51.91%)

Issuance (Repayment) of Debt Securities

-$72,000,000 (18.18%)

-$88,000,000 (-133.76%)

$260,647,000 (420.82%)

-$81,243,000 (-209.50%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$0 (0%)

$72,000,000 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

-$24,651,000 (-0.61%)

-$24,502,000 (-2.26%)

-$23,960,000 (-3.03%)

-$23,256,000 (-1.92%)

Effect of Exchange Rate Changes on Cash

-$2,721,000 (-678.94%)

$470,000 (163.43%)

-$741,000 (60.27%)

-$1,865,000 (-169.95%)

Share Based Compensation

$25,558,000 (5.36%)

$24,257,000 (11.63%)

$21,729,000 (33.02%)

$16,335,000 (24.59%)

Depreciation Amortization & Accretion

$16,605,000 (2.50%)

$16,200,000 (0.90%)

$16,055,000 (-2.66%)

$16,494,000 (-8.59%)

CNMD Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

56.10% (3.31%)

54.30% (-0.55%)

54.60% (-2.85%)

56.20% (5.24%)

Profit Margin

10.10% (94.23%)

5.20% (167.53%)

-7.70% (-224.19%)

6.20% (463.64%)

EBITDA Margin

16.60% (50.91%)

11.00% (540.00%)

-2.50% (-120.16%)

12.40% (67.57%)

Return on Average Equity (ROAE)

14.60% (78.05%)

8.20% (174.55%)

-11.00% (-232.53%)

8.30% (492.86%)

Return on Average Assets (ROAA)

5.70% (103.57%)

2.80% (173.68%)

-3.80% (-205.56%)

3.60% (620.00%)

Return on Sales (ROS)

15.30% (57.73%)

9.70% (342.50%)

-4.00% (-137.38%)

10.70% (101.89%)

Return on Invested Capital (ROIC)

13.30% (64.20%)

8.10% (379.31%)

-2.90% (-130.85%)

9.40% (147.37%)

Dividend Yield

1.20% (71.43%)

0.70% (-22.22%)

0.90% (50.00%)

0.60% (-14.29%)

Price to Earnings Ratio (P/E)

15.95 (-69.41%)

52.15 (257.67%)

-33.08 (-149.93%)

66.24 (-80.48%)

Price to Sales Ratio (P/S)

1.62 (-40.21%)

2.71 (4.72%)

2.58 (-37.01%)

4.1 (10.45%)

Price to Book Ratio (P/B)

2.2 (-45.60%)

4.04 (11.40%)

3.62 (-31.35%)

5.28 (16.84%)

Debt to Equity Ratio (D/E)

1.4 (-20.55%)

1.76 (-15.61%)

2.08 (66.83%)

1.25 (-15.10%)

Earnings Per Share (EPS)

4.29 (104.29%)

2.1 (178.36%)

-2.68 (-225.23%)

2.14 (548.48%)

Sales Per Share (SPS)

42.31 (4.53%)

40.48 (18.02%)

34.3 (-0.74%)

34.55 (14.60%)

Free Cash Flow Per Share (FCFPS)

4.98 (44.11%)

3.46 (809.74%)

0.38 (-88.53%)

3.31 (73.09%)

Book Value Per Share (BVPS)

31.16 (14.88%)

27.13 (10.91%)

24.46 (-8.93%)

26.86 (8.33%)

Tangible Assets Book Value Per Share (TABVPS)

28.59 (4.22%)

27.43 (4.49%)

26.26 (13.36%)

23.16 (4.88%)

Enterprise Value Over EBIT (EV/EBIT)

15 (-58.33%)

36 (140.91%)

-88 (-300.00%)

44 (-48.84%)

Enterprise Value Over EBITDA (EV/EBITDA)

13.9 (-56.27%)

31.8 (122.23%)

-143.05 (-470.45%)

38.62 (-37.65%)

Asset Turnover

0.57 (5.59%)

0.54 (8.48%)

0.49 (-13.91%)

0.57 (16.16%)

Current Ratio

2.3 (16.15%)

1.98 (1.07%)

1.96 (-16.24%)

2.34 (6.80%)

Dividends

$0.8 (0.00%)

$0.8 (0.00%)

$0.8 (0.00%)

$0.8 (0.00%)

Free Cash Flow (FCF)

$153,884,000 (44.74%)

$106,316,000 (818.10%)

$11,580,000 (-88.05%)

$96,904,000 (77.01%)

Enterprise Value (EV)

$3,016,513,979 (-30.65%)

$4,349,962,312 (17.40%)

$3,705,282,000 (-23.29%)

$4,830,146,731 (22.44%)

Earnings Before Tax (EBT)

$163,029,000 (101.70%)

$80,828,000 (214.06%)

-$70,862,000 (-196.93%)

$73,105,000 (4460.51%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$216,931,000 (58.57%)

$136,803,000 (628.16%)

-$25,902,000 (-120.71%)

$125,084,000 (96.37%)

Invested Capital

$1,486,418,000 (0.26%)

$1,482,516,000 (-3.08%)

$1,529,692,000 (33.64%)

$1,144,603,000 (-1.98%)

Working Capital

$361,877,000 (18.68%)

$304,920,000 (7.11%)

$284,674,000 (8.05%)

$263,477,000 (16.35%)

Tangible Asset Value

$883,226,000 (4.69%)

$843,693,000 (5.41%)

$800,364,000 (18.15%)

$677,440,000 (7.24%)

Market Capitalization

$2,114,169,979 (-37.22%)

$3,367,673,312 (24.64%)

$2,701,961,000 (-34.83%)

$4,146,071,731 (29.43%)

Average Equity

$908,018,250 (14.83%)

$790,768,500 (8.16%)

$731,099,000 (-2.88%)

$752,796,750 (8.76%)

Average Assets

$2,304,215,500 (-0.56%)

$2,317,134,500 (9.72%)

$2,111,905,250 (20.19%)

$1,757,173,750 (0.85%)

Invested Capital Average

$1,508,436,750 (0.69%)

$1,498,032,750 (2.51%)

$1,461,372,000 (26.91%)

$1,151,510,500 (-3.41%)

Shares

30,890,853 (0.45%)

30,752,199 (0.89%)

30,482,412 (4.22%)

29,247,120 (2.26%)